Patent details
EP3528852 Title: METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE
Basic Information
- Publication number:
- EP3528852
- PCT Application Number:
- US2017057328
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP178617999
- PCT Publication Number:
- WO2018075736
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE
- French Title of Invention:
- MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DE LA MALADIE DE FABRY
- German Title of Invention:
- VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON MORBUS FABRY
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 01/10/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 10/10/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 03/09/2025
- Unitary Effect Registration Date:
- 10/10/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/10/2017
- Grant date:
- 03/09/2025
- EP Publication Date:
- 28/08/2019
- PCT Publication Date:
- 26/04/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/09/2025
- EP B1 Publication Date:
- 03/09/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/10/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/08/2025
- Name:
- Sangamo Therapeutics, Inc.
- Address:
- 7000 Marina Blvd, Brisbane, CA 94005, United States (US)
Inventor
- Name:
- HUSTON, Marshall W.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201662410543 P
- Priority Date:
- 20/10/2016
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762444093 P
- Priority Date:
- 09/01/2017
- Priority Country:
- United States (US)
3
- Priority Number:
- 201762458324 P
- Priority Date:
- 13/02/2017
- Priority Country:
- United States (US)
4
- Priority Number:
- 201762502058 P
- Priority Date:
- 05/05/2017
- Priority Country:
- United States (US)
5
- Priority Number:
- 201762516373 P
- Priority Date:
- 07/06/2017
- Priority Country:
- United States (US)
6
- Priority Number:
- 201762552792 P
- Priority Date:
- 31/08/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 48/00; C12N 15/00; C12N 15/87; C12P 21/06; A61P 3/00; A61K 38/46; C12N 5/071; C12N 15/86; C12N 9/40;
Publication
European Patent Bulletin
1
- Issue number:
- 202536
- Publication date:
- 03/09/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202541
- Publication date:
- 08/10/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202545
- Publication date:
- 05/11/2025
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202546
- Publication date:
- 12/11/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|